COMMUNIQUÉS West-GlobeNewswire

I-MED Pharma partners with OCuSOFT to bring the I-PEN® Osmolarity System to the U.S.A.

08/01/2018 - 19:02

MONTREAL, Jan. 08, 2018 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the signing of an exclusive agreement with OCuSOFT Inc. for [...]

Nuvectra™ Announces Preliminary Unaudited Fourth Quarter and Full Year 2017 Revenue

08/01/2018 - 14:00

PLANO, Texas, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR ), a neurostimulation medical device company, today announced preliminary unaudited revenue for the fourth quarter and full year ended [...]

Teladoc Completes Record Visit Volume in 2017; Provides Preliminary Unaudited 2017 Results and 2018 Financial Outlook

08/01/2018 - 14:00

PURCHASE, NY, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Teladoc , Inc. (NYSE: TDOC ), today announced certain preliminary unaudited 2017 results and financial outlook for 2018. “For Teladoc, 2017 marked a landmark year as we [...]

Establishment Labs Appoints Dennis Condon to the Board of Directors

08/01/2018 - 18:22

NEW YORK, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Establishment Labs, a global medical device company focused on breast aesthetics and reconstruction technologies with a strong emphasis on product development and innovation, [...]

GUERBET : Guerbet announces its acquisition of Accurate Medical Therapeutics, an innovative company that develops microcatheters for interventional radiology

08/01/2018 - 18:12

Acceleration of the interventional radiology strategy Acquisition of a unique technology for image-guided embolization procedures Villepinte (France), January 8, 2018 (17:45 CET) - Guerbet (FR0000032526 GBT), a global [...]

GUERBET : Guerbet annonce l'acquisition d'Accurate Medical Therapeutics, société innovante dans les microcathéters pour la radiologie interventionnelle

08/01/2018 - 18:12

Accélération de la stratégie en radiologie interventionnelle Acquisition d'une technologie unique pour les procédures d'embolisation guidées par l'image Villepinte (France), le 8 janvier 2018 (17h45 heures CET) - [...]

ABLYNX ANNOUNCES BOARD CHANGES

08/01/2018 - 17:32

8 January 2018 - 5:30 pm CET GHENT, Belgium, 8 January 2018 (5:30 pm CET) - Ablynx NV [Euronext Brussels and Nasdaq: ABLX] today announced that Dr Peter Fellner, who has served as Chairman since 2013 [1] , has decided [...]

Ossur Hf : Transactions in relation to share buyback program

08/01/2018 - 17:01

Announcement from Össur hf. No. 2/2018 Reykjavík, 8 January 2018 On 15 August 2017, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2017. The purpose of the share buyback program is to [...]

Stratos Genomics Raises Funds to Ready for Commercialization

08/01/2018 - 16:00

SEATTLE, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Stratos Genomics, Inc. , a 4th generation DNA sequencing technology company, today announced it has raised $20 million in venture capital from Fisk Ventures. The funds will be [...]

I-PEN®, I-DROP® and I-PLUG® now available in Spain and Portugal through Partnership with IMEX

08/01/2018 - 15:16

MONTREAL, Jan. 08, 2018 (GLOBE NEWSWIRE) -- I-MED Pharma, Inc., a Canadian company specializing in dry eye diagnosis and management, announced today the signing of an exclusive agreement with IMEX for distribution of it [...]

I-PEN®, I-DROP® et I-PLUG® maintenant offerts en Espagne et au Portugal grâce à un partenariat avec IMEX

08/01/2018 - 15:16

MONTRÉAL, 08 janv. 2018 (GLOBE NEWSWIRE) -- I-MED Pharma inc., une entreprise canadienne spécialisée dans le diagnostic et la prise en charge de la sécheresse oculaire, a annoncé aujourd’hui la signature d’une entente [...]

HealthEquity Announces Strong Sales, Presentation at JP Morgan Healthcare Conference

08/01/2018 - 15:05

DRAPER, Utah, Jan. 08, 2018 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY ) (“HealthEquity” or the “Company”), the nation’s largest health savings account (“HSA") non-bank custodian, today announced significant [...]

Aptevo Therapeutics Begins Patient Dosing in Phase 2 Clinical Trial of Otlertuzumab in Peripheral T-Cell Lymphoma

08/01/2018 - 15:00

SEATTLE, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Aptevo Therapeutics Inc. (Nasdaq: APVO ), a biotechnology company focused on developing novel oncology and hematology therapeutics, today announced that it has commenced [...]

Alphatec Announces Preliminary Fourth Quarter and Full Year 2017 Revenue and Corporate Updates

08/01/2018 - 15:00

CARLSBAD, Calif., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“Alphatec” or the “Company”) (Nasdaq: ATEC ), a provider of innovative spine surgery solutions with a mission to improve patient lives through [...]

Progyny Reports Over 100% Revenue Growth in 2017

08/01/2018 - 15:00

New York, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Progyny, the leading fertility benefits management company, today announced it has achieved over 100% revenue growth in 2017. Progyny’s innovative carve-out fertility benefits [...]

athenahealth Announces Fourth Quarter and Full Year 2017 Earnings Conference Call

08/01/2018 - 15:00

WATERTOWN, Mass., Jan. 08, 2018 (GLOBE NEWSWIRE) -- athenahealth, Inc. (NASDAQ: ATHN ), a leading provider of network-enabled services for hospital and ambulatory clients nationwide, today announced that it will hold a [...]

Editas Medicine Reports on Recent Progress and Announces “EM22” Five-year Goals at J.P. Morgan Healthcare Conference

08/01/2018 - 15:00

By the end of 2022, Company expects to have three experimental medicines in early-stage clinical trials and two experimental medicines in or ready for late-stage clinical trials Announces first acquisition with purchase [...]

Rexahn Pharmaceuticals to Present at Biotech Showcase™ 2018

08/01/2018 - 15:00

ROCKVILLE, Md., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), a clinical stage biopharmaceutical company developing next generation therapeutics for the treatment of cancer, [...]

Resverlogix and Medison Pharma Ltd. Announce Strategic Licensing Agreement

08/01/2018 - 14:57

CALGARY, Alberta, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX: RVX ) today announced that it has entered into a licensing agreement with Medison Pharma Ltd. (“Medison”) for [...]